Locatim (previously Serinucoli) 유럽 연합 - 그리스어 - EMA (European Medicines Agency)

locatim (previously serinucoli)

biokema anstalt - Συμπυκνωμένο γαλακτοσάριον βοοειδών που περιέχει ειδικές ανοσοσφαιρίνες g έναντι προσκολλητίνης Ε. coli f5 (Κ99) - Ανοσολογικά για τα βοοειδή - Μόσχοι, νεογνά λιγότερο από 12 ώρες - Μείωση θνησιμότητας λόγω της εντεροτοξικότητας που σχετίζεται με την Ε. coli f5 (Κ99) προσκολλητίνη κατά τις πρώτες ημέρες της ζωής ως συμπλήρωμα στο πρωτόγαλα από το φράγμα.

Zeposia 유럽 연합 - 그리스어 - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod υδροχλωρική - multiple sclerosis, relapsing-remitting; colitis, ulcerative - Ανοσοκατασταλτικά - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

COLISTIN/NORMA 1.000.000 IU/VIAL POWDER FOR INHALATION 사이프러스 - 그리스어 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

colistin/norma 1.000.000 iu/vial powder for inhalation

norma hellas s.a. (0000008859) 54, menandrou street, athens, gr 10431 - colistimethate sodium - powder for inhalation - 1.000.000 iu/vial - colistimethate sodium (0021362083) 1000000iu

BCG VACCINE SSI PS.INJ.SUS 2-8x10 6 CFU/ML 그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

bcg vaccine ssi ps.inj.sus 2-8x10 6 cfu/ml

statens serum institut, denmark artillerivej 5,, dk-2300 copenhagen s 45 32 68 32 68 - mycobacterium bovis (bcg) danish strain 1331 - ps.inj.sus (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 2-8x10 6 cfu/ml - mycobacterium bovis (bcg) danish strain 1331 - tuberculosis, live attenuated

COLITAB 3M 3MU/BOLUS ΒΟΛΟΙ 그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

colitab 3m 3mu/bolus βολοι

agroseed candilidis a.e. (0000006125) Παπαδά 2 & Μεσογείων,,115 25,Αθήνα,gr - ΘΕΙΙΚΉ ΚΟΛΙΣΤΊΝΗ - ΒΟΛΟΙ - 3mu/bolus - colistin sulfate 3,00 bolus 3mu/bolus - colistin - colistin - Χρόνοι αναμονής:

COLIVETO VMD ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ 그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

coliveto vmd κονισ για ποσιμο διαλυμα

nutri-biomed ΕΛΛΑΣ ΕΠΕ (0000008003) Β. Ουγκώ 1 & Χλόης 98,,144 52,144 52, Μεταμόρφωση,gr - ΘΕΙΙΚΉ ΚΟΛΙΣΤΊΝΗ - ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ - colistin sulfate 40,00 pd.ora.sol - colistin - colistin - Χρόνοι αναμονής:

BCG VACCINE AJVACCINES PS.INJ.SUS 2-8x10 6 CFU/ML 그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

bcg vaccine ajvaccines ps.inj.sus 2-8x10 6 cfu/ml

aj vaccines a/s, denmark artillerivej 5, dk-2300 copenhagen s +45 7229 7000 - mycobacterium bovis (bcg) danish strain 1331 - ps.inj.sus (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 2-8x10 6 cfu/ml - mycobacterium bovis (bcg) danish strain 1331 0ml - tuberculosis, live attenuated

Regkirona 유럽 연합 - 그리스어 - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - Άνοσοι οροί και ανοσοσφαιρίνες, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Veklury 유럽 연합 - 그리스어 - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Xevudy 유럽 연합 - 그리스어 - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - Άνοσοι οροί και ανοσοσφαιρίνες, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.